Skip to content

A clinical study on relief from Ajeerna (Indigestion) using Jeerak (Jeera) and Pashchimottanasana

Clinical Evaluation of Jeerak and Pashchimottanasana Practice in Ajeerna (Indigestion) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096711
Enrollment
50
Registered
2025-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

None listed

Sponsors

Yudhi Sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Individuals having digestive problems. 2.Individuals who were fully cooperative for the study. 3.Individuals with informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Individuals not willing for the trial. 2.Patients suffering from gastroesophageal reflux disease (GERD), peptic ulcers, irritable bowel syndrome (IBS), Crohn’s disease, and ulcerative colitis. 3. Patients undergoing any abdominal surgical procedures. 4. Patients not addicted to tobacco, smoking and alcohol. 5. Individual who’s taking any medicine for digestion and acidity. 6. Individuals who take any medicine for digestion, constipation and acidity during this study of 60 days.

Design outcomes

Primary

MeasureTime frame
To assess the combined effect of jeerak and pashchimottanasana in patients of ajeerna.Timepoint: 1. Baseline at day 1 before onset of treatment. 2. Follow up after every 15 days. 3. 2 months after onset of treatment.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Smita Zambare

Department of Swasthavritta and Yoga, Uttaranchal Ayurvedic College, 17, Old Mussoorie Rd, Kairwaan Gaon, Dehradun, Uttarakhand, India

smitazambare1@gmail.com8879133317

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026